AXIOS February 7, 2024
Maya Goldman

If Donald Trump returns to the White House, the self-proclaimed master negotiator could get his shot at brokering Medicare prices for drugs.

Why it matters: Trump first ran for president bucking conservative orthodoxy by vowing to negotiate drug prices, though he later abandoned that pledge.

  • But the Democrats’ drug pricing law would require the GOP frontrunner to negotiate Medicare prices for some drugs if he wins a second term, and former Trump health officials expect he would use executive power to soften the government’s approach.

Catch up quick: The Biden administration last week kicked off negotiations over the first set of 10 high-cost drugs, a milestone for Democrats who long supported leveraging the government’s purchasing power to rein...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
109 hospitals receiving new Medicare-backed residency slots
Senators urge Congress to avert Medicare physician pay cut
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes

Share This Article